6.15 配料創新 達能開放科研中心 王旖-中文.pdf

《6.15 配料創新 達能開放科研中心 王旖-中文.pdf》由會員分享，可在線閱讀，更多相關《6.15 配料創新 達能開放科研中心 王旖-中文.pdf（31頁珍藏版）》請在三個皮匠報告上搜索。

1、誰能“吹”散我們的“腦霧”達能中國開放科研中心王旖 博士新冠感染的神經病變與腦功能改變目錄HEALTHY AGING營養與腦血管功能消費者對腦健康的需求改善睡眠營養素與腦功能抗炎抗氧化營養素與腦功能新冠期間中國人群關注健康焦點HEALTH CONCERN SINCE COVID-19 CHINAHEALTHY AGING2022年11月，世界衛生組織在更新版的新冠肺炎個人康復指南里，引入了一個新的新冠后遺癥名詞“腦霧”。在新冠患者康復過程中，可能會出現思維能力(稱為“認知”)的各種困難，包括記憶力、注意力、信息處理、計劃和組織方面的問題，被稱為“腦霧”。什么是腦霧WHAT IS BRAIN F

2、OGHEALTHY AGINGCShort term(4Short term(4-12 weeks after COVID12 weeks after COVID-19 diagnosis)19 diagnosis)Long term(12 weeks after COVIDLong term(12 weeks after COVID-19 diagnosis)19 diagnosis)Fatigue(51%,95%CI 39-64%,low certainty)General pain or discomfort(40%,95%CI 24-58%,low certainty)Shortnes

3、s of breath(38%,95%CI:27-51%,very low certainty)Sleep disturbances(26%,95%CI 24-29%,low certainty)Anxiety(29%,95%CI:16-48%,very low certainty)Cough(28%,95%CI:22-35%,low certainty)Fatigue(47%,95%CI 27-68%,very low certainty)General pain or discomfort(27%,95%CI 25-29%,low certainty)Sleep disturbances(

4、26%,95%CI 24-29%,low certainty)Shortness of breath(22%,95%CI 12-35%,very low certainty)Anxiety or depression(22%,95%CI 19-25%,low certainty)Depression or post-traumatic stress disorder(22%,95%CI 12-32%,very low certainty)Hair loss(22%,95%CI 20-24%,low certainty)https:/covid19-sciencetable.ca/science

5、brief/understanding-the-post-covid-19-condition-long-covid-and-the-expected-burden-for-ontario/?154,068 人COVID-19隊列VS 5,638,795 對照組，5,859,621歷史對照新冠感染后與腦相關癥狀RISKS AND 12-MONTH BURDENS OF INCIDENT POST ACUTE COVID-19 NEUROLOGIC OUTCOMESLong-term neurologic outcomes of COVID-19.Nat Med 28,24062415(2022

6、).HEALTHY AGINGC肺功能心腦：炎性反應血管神經：（睡眠、認知）肝功能新冠感染對健康的影響新冠感染對健康的影響IMPACT OF COVID-19 AND POST-COVID CONDITION ON VARIOUS ORGAN SYSTEMShttps:/doi.org/10.47326/ocsat.2021.02.44.1.0HEALTHY AGINGC薈萃分析：新冠的輔助改善方案薈萃分析：新冠的輔助改善方案OVERVIEW OF SOME PROPOSED PHARMACOLOGICAL AGENTS WITH POTENTIAL BENEFICIAL EFFECTS IN

7、 COVID-19 PATIENTHEALTHY AGINGPharmacology&Therapeutics 219(2021)107703新冠感染對腦神經的作用機制新冠感染對腦神經的作用機制POTENTIAL MECHANISMS OF COVID-19 IN NEURAL SYSTEMHEALTHY AGINGCHEALTHY AGING新冠感染對心腦血管健康的作用機制新冠感染對心腦血管健康的作用機制POTENTIAL MECHANISMS OF SARS-COV-2-INDUCED CARDIOVASCULAR COMPLICATIONSWHO WHO 關于腦健康康復指導關于腦健康康復

8、指導HEALTHY AGINGCN N-3 3 脂肪酸對心血管和炎性反應的影響脂肪酸對心血管和炎性反應的影響POTENTIAL CARDIOPROTECTIVE AND ANTI-INFLAMMATION MECHANISMS OF N-3 PUFAS IN THE SETTING OF COVID-19Darwesh AM,Bassiouni W,Sosnowski DK,SeubertJM.Pharmacol Ther.2021 Mar;219:107703.HEALTHY AGINGn-3 supplements have been found to be 12 to 21%effect

9、ive in reducing the risk of Covid-19.Increasing severity of the disease and the need for mechanical ventilation and hospitalization due to polyunsaturated fatty acid deficiencyn-3 fatty acid deficiency increased mortality in patients with Covid-19.Elevated levels of fatty acids in patients lungs and

10、 a cytokine storm are the main reasons for mortality in Covid-19 patients.薈萃分析：薈萃分析：N N-3 3 脂肪酸與新冠脂肪酸與新冠POLYUNSATURATED FATTY ACIDS ON THE SEVERITY AND MORTALITY OF COVID PATIENTS:A SYSTEMATIC REVIEWLife Sciences 299(2022)120489他汀類在輔助治療中的應用他汀類在輔助治療中的應用STATINS IN COVID-19 THERAPYHEALTHY AGINGCLife(Ba

11、sel).2021 Jun 16;11(6):565.維生素C與肺炎、感染和新冠感染VITAMIN C DEFICIENCY IN PNEUMONIA,SEPSIS AND COVID-19Study TypeCohortVitamin C(mol/L)(%Deficient,%Hypovitaminosis C)PneumoniaCase controlHealthy volunteers(n=50)56 2a(0%b,8%c)Community-acquired pneumonia(n=50)23 3(22%,62%)Case controlHealthy volunteers(n=20)

12、66 3Pneumonia cases(n=11)31 9Intervention(placebo group)Pneumonia/bronchitis(n=29):Week 024 5(40%)bWeek 219 3(37%)Week 424 6(25%)Intervention(control group)Pneumonia cases(n=70):Day 041Day 5102324Day 15203235Day 3039SepsisIntervention(baseline)Sepsis with ARDS(n=83):Day 022(1137)dDay 223(937)Day 426

13、(941)Day 729(1239)ObservationalSeptic shock patients(n=24)15 2(38%b,88%c)Intervention(baseline)Severe sepsis patients(n=24)18 2Severe COVID-19ObservationalCritically ill COVID-19(n=21)22 4(45%b,70%c)eSurvivors(n=11)29 7(40%,50%)Non-survivors(n=10)15 2(50%,90%)ObservationalCOVID-associated ARDS(n=18)

14、17 with 9 mol/L1 with 14 mol/LNutrients.2020 Dec 7;12(12):3760.HEALTHY AGINGPatientsPatientsInterventionInterventionDose(Duration)Dose(Duration)Patient OutcomesPatient OutcomesPneumoniaPneumoniaPneumonia/bronchitis(n=57):Oral vitamin C(28 day):respiratory symptom score in most severely illPlacebo(n=

15、29)0 g/day17%mortality in placebo groupTreatment(n=28)0.2 g/day4%mortality in treatment groupPneumonia(n=140):Oral vitamin C(10 day):hospital length of stay:Control(n=70)0 g/day24 days in control groupLow dose(n=39)0.250.8 g/day19 days in low dose groupHigh dose(n=31)0.51.6 g/day15 days in high dose

16、 groupSepsisSepsisSepsis and ARDS(n=167):IV vitamin C(4 day):X systemic organ failure scoreX C-reactive protein,thrombomodulinX ventilator-free days28 day mortalityICU-free dayshospital-free daysPlacebo(n=83)0 mg/kg bw/dayTreatment(n=84)200 mg/kg/daySeptic shock(n=100):IV vitamin C(until ICU dischar

17、ge)vasopressor durationICU length of stayX length of mechanical ventilationX renal replacement therapyX ICU mortalityPlacebo(n=50)0 g/dayTreatment(n=50)6 g/daySeptic shock(n=28):IV vitamin C(3 day):norepinephrine dose and duration28 day mortalityX ICU length of stayPlacebo(n=14)0 mg/kg bw/dayTreatme

18、nt(n=14)100 mg/kg bw/daySevere sepsis(n=24)IV vitamin C(4 day):systemic organ failure scoreC-reactive protein,procalcitonin,thrombomodulinPlacebo(n=8)0 mg/kg bw/dayLow dose(n=8)50 mg/kg bw/dayHigh dose(n=8)200 mg/kg bw/daySevere COVIDSevere COVID-1919Critical COVID-19(n=54)IV vitamin C(7 day):X vent

19、ilation-free daysPaO2/FiO2Interleukin-628 day mortality in patients with SOFA scores 345 項目應用VC的臨床研究45 CLINICALTRIALS.GOV INVESTIGATING VITAMIN C WITH OR WITHOUT OTHER TREATMENTS FOR COVID-19.HEALTHY AGINGThe 28-day mortality from randomization(day 1)to day 28 in a trial of high-dose intravenous vit

20、amin C(HDIVC)in patients with COVID-19.維生素C與肺炎、感染和新冠感染VITAMIN C DEFICIENCY IN PNEUMONIA,SEPSIS AND COVID-19HEALTHY AGING褪黑素在新冠病毒感染中的應用POTENTIAL EFFECTS OF MELATONIN ON THE COURSE OF COVID-19COVID-19 PhaseEffect of Melatonin TreatmentRecommended DoseProphylaxisCircadian sleepwake rhythm disorder trea

21、tment0.55 mgInsomnia treatmentAdjuvant to anti-SARS-CoV-2 vaccines25 mg10.52 mg2Early infection phase/mild clinical symptomsImprovement of sleep qualityInhibition of viral invasionFree oxygen species scavengingCytokine suppression212 mg3Pulmonary phase/severe clinical symptomsImprovement of sleep qu

22、alityAnti-inflammatory effectsReduction of“cytokine-storm”Protection of lungs and tissues from oxidative injuryRisk reduction of ventilator-induced lung injury212 mg3,4Post-infection periodImprovement of sleep qualityStabilization of the disrupted circadian sleep rhythmAntioxidant propertiesReductio

23、n of post-covid pulmonary fibrosis0.55 mgInt J Mol Sci.2021 Aug;22(16):8623.HEALTHY AGING維生素D、鋅、硒與感染POTENTIAL EFFECTS OF VITAMIN D、ZINC、SELENIUM ON THE COURSE OF COVID-19Adequate supply of zinc,selenium,and vitamin D is essential for resistance to other viral infections,immune function,and reduced i

24、nflammation.Initiation of adequate supplementation in high-risk areas and/or soon after the time of suspected infection with SARS-CoV-2.2020 Aug 7;12(8):2358.Nutrients.2020 Aug 7;12(8):2358.HEALTHY AGINGC腦霧 VS 認知衰退BRAIN FOG VS COGNITIVE DECLINE HEALTHY AGING20銀發一代：中國人口老齡化銀發一代：中國人口老齡化SILVER AGE:CHINA

25、S AGING POPULATIONPopulation and health issues in the 60+2020-2040來源：國家衛生健康委員會2022年9月20日新聞發布會上海市健康老齡化行動方案（2022-2025年）267 Million18.9%At the end of 2021400+Million30%+203515 MillionDementia10 MillionAlzheimers disease認知障礙患者快速增長21認知障礙患者中13%處于“中年”（41-60歲）老年人認知功能和腦健康COGNITIVE DECLINE WITH AGEHEALTHY AGI

26、NGCHEALTHY AGING老年人認知功能和腦健康風險因素COGNITIVE DECLINE WITH AGE MODIFIABLE FACTORS THROUGHOUT COURSE OF LIFEJin-Tai Yu et al.J Neurol Neurosurg Psychiatry doi:10.1136/jnnp-2019-321913HEALTHY AGINGC老年人抗氧化劑需求與腦健康LOW DIETARY VITAMIN E INTAKE IS ASSOCIATED WITH HIGH RISK OF INCIDENT DEMENTIA AMONG OLDER ADULT

27、S:THE SHANGHAI AGING STUDYCumulative incidence rate of dementia I Increased most dramatically after almost 4 ncreased most dramatically after almost 4 years of followyears of follow-up in vitamin E low intake up in vitamin E low intake participants Association between vitamin E intake level and risk

28、 of dementiaAssociation between vitamin E intake level and risk of dementiaHEALTHY AGINGVitamin E intake levelVitamin E intake levelPersonPerson-yearsyearsIncidence,100 Incidence,100 personperson-year,(%)year,(%)HR(95%CI)*P valueLow intake group(13.20mg/d)Low intake group(23.63mg/d)High intake group

29、(23.63mg/d)2098.80.71Yi Wang et al Front Nutr.2022 Nov 23;9:1036795.24LPC-DHA脂肪酸在血腦屏障（BBB）轉運1 ZhangW,ChenR,YangT,etal.Fatty AcidTransporting Proteins:RolesinBrainDevelopment,Aging,and StrokeJ.ProstaglandinsLeukotrienes&EssentialFatty Acids,2017:S0952327817300212.2 Chouinard-WatkinsR,LacombeR,Bazinet

30、RP.Mechanisms regulating brain docosahexaenoicacid uptake:what is therecent evidence?J.CurrentOpinioninClinical Nutrition&Metabolic Care,2018:1.3Berger JH,Charron MJ,Silver D L,et al.Major Facilitator Superfamily Domain-ContainingProtein 2a(MFSD2A)Has Rolesin BodyGrowth,Motor Function,and Lipid Meta

31、bolismJ.PLoSONE,2012,7(11):e50629.腦健康營養素的優化HEALTHY AGINGHEALTHY AGINGC魚油和膽堿聯合攝入改善認知25魚油和膽堿的聯合攝入影響炎性因子、細胞凋亡和神經元營養因子等提高小鼠學習記憶能力魚油和膽堿的聯合攝入促進大腦中DHA轉運魚油和膽堿的聯合攝入改善大腦中膽堿能神經系統HEALTHY AGINGC“智敏捷”-有關腦健康的臨床驗證FORTASYN CONNECT DESIGNED TO SUPPORT SYNAPSE FORMATION,PRESERVE MEMORY AND COGNITIONBRAIN BRAIN-NEUROPR

32、OTECTIONNEUROPROTECTIONPreserve brain integrity,cognition and memoryPreserve brain integrity,cognition and memory Memory loss is among the biggest concerns while aging NormalNormalagingagingbrainbrainfunctionfunctionpeakspeaksin 20in 20-30s 30s andanddeclinesdeclinesthroughoutthroughoutlifelife Nutr

33、iciahas proprietary engine,FortasynFortasynconnect connect that can be leveraged in HA Earlier intervention with Earlier intervention with SouvenaidSouvenaidbrings larger brings larger benefit benefit preserve memory and prevent brain preserve memory and prevent brain shrinkageshrinkage 15 publicati

34、ons on clinical studies with FC/15 publications on clinical studies with FC/SouvenaidSouvenaid Multimodal lifestyle intervention including Souvenaidongoing Strong IP portfolio 30 patentsStrong IP portfolio 30 patents0122436-0.6-0.4-0.20.00.2Tim e after baseline(m onths)Im provem en t0122436-45-30-15

35、0Tim e after baseline(m onths)Im provem en tAbilityAbilityto to processprocessinformation information andandmemory are memory are impactedimpactedbybynormalnormalagingagingEarlierEarlierinterventioninterventionwithwithSouvenaidSouvenaidbringsbringslargerlargerbenefitbenefitMemoryBrain volumeSouvenai

36、dSouvenaidcontains contains FortasynFortasynConnect Connect-a unique a unique combination of nutrients designed to support synapse combination of nutrients designed to support synapse formationformationTHE ENGINE THE ENGINE FORTASYN CONNECTFORTASYN CONNECTPROVEN EFFICACYPROVEN EFFICACYAGING IMPACTAG

37、ING IMPACTBrain volume Brain volume andandSynapseSynapsenumbernumberdeclinedeclinewithwithageage從食物到特殊醫學用途營養品FROM DIET TO MEDICAL NUTRITION PRODUCTSFROMDESIGN THINKING TOEVIDENCE BASEDHEALTHY AGINGSLEEP DISORDER16 June,2023PRESENTATION TITLE IN CALIBRI BOLD2 MAJOR CATEGORIESDYSSOMNIA-Amount-Quality-

38、Timing PARASOMNIA-Abnormal Behavior During Sleephttps:/circadiansleepdisorders.org/info.php老年人的睡眠障礙LIFESTYLE AND SLEEP HYGIENE COUNSELLINGTREATMENT OF UNDERLYING MEDIAL CONDITION(IF ANY)Somatic Psychological Other sleep disorder NON PHARMACOLOGICAL TREATMENT Cognitive behavior therapy Chronotherapie

39、s(sleep restriction,light therapy)NIH(2005)NICE(2004/2007)ESTILVILL ET AL(2003)CLIN DRUG INVEST 23(6):351-385.*PHASE III.16 June,2023老年人睡眠管理需求PHARMACOTHERAPY GABA-erg(nonBZD)hyperarousal MT-erg(MLT-PR,tasimelteon*)CRZ-type Orexinerg(almorexant*)Certain antidepressives(off label in Europe)Tsuneki,H.,

40、Sasaoka,T.,&Sakurai,T.(2016).Sleep Control,GPCRs,and Glucose Metabolism.Trends in Endocrinology&Metabolism,27,633-642.HEALTHY AGING*僅供內部使用，如需對外使用，需通過內部POSM審核ORIENTAL COMBO FOR SLEEP1GABA,spine date seed2WESTERN COMBO FOR BRAIN3Imported fish oilMulti-vitaminsOnly for internal use,if need to communicate with consumers,need to go trough internal POSM audit.感謝聆聽